Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.

Shohei AnnoTadashi OkanoKenji MamotoYutaro YamadaKoji MandaiKazuki OritaTakahiro IidaMasahiro TadaKentaro InuiTatsuya KoikeHiroaki Nakamura

Published in: Modern rheumatology (2024)

Clinical efficacy of JAKi in D2T RA group did not differ from that in 2nd and non-D2T RA groups. Glucocorticoid use and multiple bDMARD/JAKi failure were poor prognostic factors for D2T RA.

Keyphrases

rheumatoid arthritis
prognostic factors
disease activity
ankylosing spondylitis
interstitial lung disease
systemic sclerosis